Menu
Not yet recruiting NCT07029464

Comparison of Short- and Long-term Outcomes Between Robotic and Laparoscopic Hemicolectomy of Right Colon Cancer : A Multicenter Propensity Score Matching Analysis

Observational Robotic Surgical Procedures Right Colon Tumors Cancer Laparoscopic Abdominal Surgery

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Robotic Surgical Procedures, Right Colon Tumors, Cancer, Laparoscopic Abdominal Surgery. Basic parameters: 18 years — 80 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

This is a retrospective, multicenter cohort study to compare short- and long-term outcomes between robotic and laparoscopic hemicolectomy of right colon cancer.

Primary outcome measures

  • 3-year overall survival (OS) rate and 3-year disease-free survival (DFS) rate [Time frame: (OS)From post-operation until death or the 3-year study endpoint (DFS)From post-operation to tumor recurrence or the 3-year study endpoint]
Secondary outcome measures (10)
  • Operative time [Time frame: Periprocedural]
  • Intraoperative blood loss [Time frame: Periprocedural]
  • Time to first flatus/bowel movement [Time frame: Periprocedural]
  • Time to liquid diet initiation [Time frame: Periprocedural]
  • Time to ambulation [Time frame: Periprocedural]
  • Postoperative hospital stay duration [Time frame: Up to 30 days]
  • Postoperative complications [Time frame: From end of surgery to 30 days postoperatively]
  • Postoperative white blood cell (WBC) count [Time frame: On postoperative days 1, 3, and 5]
  • Postoperative C-reactive protein (CRP) level [Time frame: On postoperative days 1, 3, and 5]
  • Pain score [Time frame: On postoperative days 1, 3, and 5]

Eligibility criteria

Inclusion criteria

  • 1.Underwent radical right hemicolectomy by Da Vinci robotic or laparoscopic surgery 2.Postoperative pathology confirmed right colon adenocarcinoma (pT2-T4aNxM0; including cecal adenocarcinoma, ascending colon adenocarcinoma, hepatic flexure colon adenocarcinoma, and proximal transverse colon adenocarcinoma) 3.Complete clinical data and pathological results available

Exclusion criteria

  • 1.Received neoadjuvant therapy prior to surgery 2.History of other malignancies in the past 5 years (except cured cervical carcinoma in situ, basal cell carcinoma, or squamous cell carcinoma of the skin) 3.Distant metastases (e.g., liver, lung) or extensive abdominal/pelvic metastases confirmed by contrast-enhanced CT, PET-CT, or intraoperative exploration 4.Comorbid neurological/psychiatric disorders impairing ability to express informed consent 5.Poor systemic condition with contraindications to general anesthesia 6.Severe obesity (BMI >35 kg/m²) 7.Severe widespread abdominal adhesions precluding safe pneumoperitoneum establishment 8.Emergency surgery due to tumor perforation or obstruction 9.Refusal to provide informed consent

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07029464 · IITS2025462

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗